🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔥 #PCRLV 🇬🇧 2024 Late-breaking Trials: Spotlight on TRISCEND II A study to ascertain whether Transcatheter Valve Replacement improves outcomes in symptomatic severe tricuspid regurgitation Outcome 📊: TTVR was superior to medical therapy for the primary composite outcome in

One-year results of a randomised study comparing two balloon 🎈expandable #TAVI valves: watch Guillaume Bonnet's interview with Henrik Nissen to get the key points of the COMPARE TAVI LBT just presented at #PCRLV Pamela Gatto Ana Paula Tagliari Doc. Dr. Serkan Asil Mi Chen 陈密 Jonathan Curio

🆕Hot off the press at #PCRLV: 30D outcomes of TF J-VALVE for Chronic AR. Alessandro Beneduce asked Lai Wei to comment on the trial he just presented in the Top Late-Breaking Trials session Pamela Gatto Ana Paula Tagliari Doc. Dr. Serkan Asil Guillaume Bonnet Mi Chen 陈密 Jonathan Curio Fiona Kelly

Please feel free to share and use our #PCRLV 🇬🇧 2024 visuals created specially for a selection of top Late-breaking Trials presented at PCR London Valves! pcronline.com/News/Whats-new… #TAVI #TreatTR #FixTR #clinicaltrials

Great new #PCRLV 2024 track:Innovation💡 🎯identify unmet need 🎯find a team 🎯ask 4 help early ➡️check program 4 "Innovation" Pamela Gatto Ana Paula Tagliari Doc. Dr. Serkan Asil Guillaume Bonnet Mi Chen 陈密 Denisa Muraru Tianyuan Alessandro Beneduce Harriet Hurrell Lynne Hinterbuchner Marcio Montenegro Edoardo Zancanaro MD

I know many operators have shifted their second-choice #TAVI access to the #carotid artery. 💫However, having a PhD focused on #axillary access, I feel compelled to highlight that this can also be a safe and effective option when performed correctly. 🎯The key is to follow

💡 Abstract sessions at #PCRLV 2024: A hub of innovation and discussion! The Innovalve TMVR system shows exciting potential on this monocentric experience : ✔️ Anchored valve via central wrapping ✔️ No LVOT obstruction ✔️ MR reduced to ≤1+ in all patients ✔️ Significant

Presented on Day 1 at #PCRLV: the TRISCEND II trial evaluated #TMVR vs. medical therapy for tricuspid regurgitation. If you missed the session and want to get to the essential, watch this short interview with Raj Makkar by Edoardo Zancanaro MD! Pamela Gatto Ana Paula Tagliari Doc. Dr. Serkan Asil

🎯 Tricuspid innovations at #PCRLV 2024! Thomas Modine thomas modine presented groundbreaking results with a new percutaneous tricuspid valve replacement device LUX 🫀: ✔️ Exceptionally low rates of post-procedure pacemaker implantation ✔️ Promising outcomes that push the

🎯Check out the main conclusions from the Tricuspid Hotline Late- Breaking Trials just presented at #PCRLV 1.Transcatheter valve repair for tricuspid regurgitation: one-year results from a real- world registry by J. Hausleiter 2.TriCLASP study one-year results by J. Hausleiter

What’s the role of #TTVR vs. #TriClip? Let’s see what thomas modine, an TTVR expert had said #Evoque #Edwards #CardioValve #LuXValve #Jenscare PCRonline 🫀 Ana Paula Tagliari Edoardo Zancanaro MD Mi Chen 陈密 Marcio Montenegro Alessandro Beneduce Lynne Hinterbuchner Jonathan Curio Doc. Dr. Serkan Asil Harriet Hurrell

Exciting discussions on cutting-edge technologies at #PCRLV! Ana Paula Tagliari asked Azeem Latib to share key messages from the innovation sessions💡!

Amazing Zen experience!! NAPs and companion community #PCRLV Matteo Longoni Sarah Carson Ana Paula Tagliari Edoardo Zancanaro MD Mi Chen 陈密 Marcio Montenegro Alessandro Beneduce Jonathan Curio Doc. Dr. Serkan Asil Harriet Hurrell

Whole AS liftetime in just 1 hour: Possible @ #PCRLV Simulation Lab 🎯Alignment+coronary access are key ➡️Simulation teaches all new techniques Arif Khokhar Pamela Gatto Ana Paula Tagliari Doc. Dr. Serkan Asil Guillaume Bonnet Mi Chen 陈密 Denisa Muraru Tianyuan Alessandro Beneduce Harriet Hurrell Edoardo Zancanaro MD

📢 Join the #EAPCIJournalClub for an exciting follow-up to our #PCRLV discussions! 📚 Dive into the Matterhorn trial with the experts and make your voice heard—ask your questions in the comments! 🗓️ 29 November 2024 ⏰ 18:00-19:00 🔗 Register for FREE EAPCI is our

🔎When should we use Cardiac MRI in patients with aortic stenosis or regurgitation? Harriet Hurrell asked João Cavalcante to share the key messages from his session at #PCRLV. #TAVI #TAVR

#PCRLV 2024 with TRISCEND #tricuspid ✈️ #TR reduction ❤️ ⬆️ KCCQ Listen from authors 🔈 Ana Paula Tagliari Mi Chen 陈密 Marcio Montenegro Alessandro Beneduce Lynne Hinterbuchner Jonathan Curio Doc. Dr. Serkan Asil Harriet Hurrell Tianyuan Guillaume Bonnet Fiona Kelly Denisa Muraru Pamela Gatto EAPCIPresident

There are many people to thank after this exceptional edition of #PCRLV 🇬🇧 2024, but we would like to extend a particular 🙏🙏 to the fabulous #SoMe #Heartteam, led by Pamela Gatto ! Ana Paula Tagliari Doc. Dr. Serkan Asil Guillaume Bonnet Mi Chen 陈密 Jonathan Curio Fiona Kelly Denisa Muraru

Thanks to CircInterventions for publishing! 3 year outcomes of BYPASS-CTCA suggestive of ongoing MACE benefit of CTCA prior to angio in CABG pts, which we hope to prove in a larger National Institute for Health and Care Research funded multi-centre trial coming soon...Barts Interventional Group (B.I.G.) Charles Knight OBE Barts Cardiovascular Clinical Trials Unit William Harvey Research Institute

Dr Madalina Garbi on mitral regurg Phenotyping is really important #echofirst